QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

RBC Capital analyst Ben Hendrix maintains Ardent Health (NYSE:ARDT) with a Outperform and lowers the price target from $21 t...

Core News & Articles

Truist Securities analyst David Macdonald maintains Ardent Health (NYSE:ARDT) with a Buy and lowers the price target from $2...

Core News & Articles

Stephens & Co. analyst Scott Fidel maintains Ardent Health (NYSE:ARDT) with a Overweight and lowers the price target fr...

Core News & Articles

Morgan Stanley analyst Craig Hettenbach downgrades Ardent Health (NYSE:ARDT) from Overweight to Equal-Weight and lowers the ...

Core News & Articles

B of A Securities analyst Kevin Fischbeck maintains Ardent Health (NYSE:ARDT) with a Underperform and lowers the price targe...

Core News & Articles

Ardent Health (NYSE:ARDT) lowers FY2025 GAAP EPS guidance from $1.73-$2.01 to $0.85-$1.03 vs $1.85 analyst estimate. Affirms FY...

Core News & Articles

Ardent Health Partners (NYSE:ARDT) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate o...

Core News & Articles

Goldman Sachs analyst Scott Fidel initiates coverage on Ardent Health (NYSE:ARDT) with a Neutral rating and announces Price...

Core News & Articles

UBS analyst A.J. Rice initiates coverage on Ardent Health (NYSE:ARDT) with a Buy rating and announces Price Target of $17.

Core News & Articles

- SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION